Epitope distribution in ordered and disordered protein regions. Part B — Ordered regions and disordered binding sites are targets of T- and B-cell immunity

Intrinsically disordered proteins exist in highly flexible conformational states linked to different protein functions. In this work, we have presented evidence that HLA class-I- and class-II-binding T-cell epitopes, experimentally verified in several tumor-associated antigens and nuclear systemic a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of immunological methods 2014-05, Vol.407, p.90-107
Hauptverfasser: Pavlovic, Mirjana D, Jandrlic, Davorka R, Mitic, Nenad S
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 107
container_issue
container_start_page 90
container_title Journal of immunological methods
container_volume 407
creator Pavlovic, Mirjana D
Jandrlic, Davorka R
Mitic, Nenad S
description Intrinsically disordered proteins exist in highly flexible conformational states linked to different protein functions. In this work, we have presented evidence that HLA class-I- and class-II-binding T-cell epitopes, experimentally verified in several tumor-associated antigens and nuclear systemic autoantigens, are predominantly located in ordered protein regions or at disorder/order borderlines, defined by the majority of analyzed publicly available disorder predictors. We have also observed the overlapping of secondary structural elements and prevalently hydrophobic regions with T-cell epitopes in Epstein Barr Virus (EBV) nuclear antigen 1 (EBNA-1), cancer/testis antigen MAGE-A4, and Sm-B/B′, U1 snRNPA (U1A) and U1-70kDa autoantigens. The results are in accordance with the clustering of the predicted HLA class-I and class-II epitopes in protein parts which encompass the consensus of ordered regions, determined by individual disorder predictors. Some HLA class-II epitopes and linear B-cell epitopes were located near the segments predicted to have elevated crystallographic B factor in EBNA-1, Sm-B/B′ and U1 snRNP A proteins, suggesting that protein flexibility could influence the structural availability of epitopes. Naturally processed T-cell epitopes and linear B-cell epitopes could also be found within putative disordered binding sites, determined by “dips” in the prevalently disordered parts of prediction profiles of the majority of disorder predictors, and peaks in ANCHOR-prediction profile. Two minor antigenic regions within EBNA-1, mapped to the residues 58–85 and 398–458, encompassing putative disordered binding sites, contain epitopes connected with anti-Ro 60kDa and anti-Sm B/B′ autoimmunity in systemic lupus erythematosus. One of these regions overlaps residues 395–450, identified as the binding site of USP7 (HAUSP), which regulates the EBNA-1 replication function. In Sm-B/B′, one of the putative disordered binding sites (residues 114–165) encompasses the T-cell epitope 136–153, while another, residues 200–216, flanks two proline-rich B-cell epitopes (residues 190–198 and 216–222), overlapping the preferred CD2BP2–GYF-binding motif (R/K/G)XXPPGX(R/K), characteristic of splicosomal proteins. We have noticed that the same motif (residues 397–403) is mimicked in EBNA-1 and overlaps epitope 398–404, involved in anti-Sm B/B′ autoimmunity. The majority of recognized T- and B-cell epitopes in analyzed autoantigens or tumor-associated antigens appertain
doi_str_mv 10.1016/j.jim.2014.03.027
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1773826366</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022175914001161</els_id><sourcerecordid>1529841903</sourcerecordid><originalsourceid>FETCH-LOGICAL-c386t-3526b37e1bdeed73b746599c7329bd642dbd17e5fa14a0b262212af757794ee93</originalsourceid><addsrcrecordid>eNqFkc1u1DAUhS0EokPhAdggL9kkXNuJHYsVrcqPVKldlLVlxzcjjybJYDtI3fUh2PJyPAmezpRFF2V1ZZ3vHN3rQ8hbBjUDJj9s6k0Yaw6sqUHUwNUzsmKd4pXS0D4nKwDOK6ZafUJepbQBAAYSXpIT3iguO9muyO-LXcjzDqkPKcfglhzmiYaJztFjRE_t5Pfaw3MX54xFjrguYKrptY2ZntE_d7_o1ZE5ao-tLkw-TGuaQsYiRqTZxjXmROeB3lT3-FnV43ZLwzguU8i3r8mLwW4TvjnOU_L988XN-dfq8urLt_NPl1UvOpkr0XLphELmPKJXwqlGtlr3SnDtvGy4d54pbAfLGguOS84Zt4NqldINohan5P0ht5z3Y8GUzRjSfhM74bwkw5QSHZdCyv-jLdddwzSIgrID2sc5pYiD2cUw2nhrGJh9gWZjSoFmX6ABYUqBxfPuGL-4Ef0_x0NjBfh4ALD8x8-A0aQ-4NSjDxH7bPwcnoj_C6WOrZ4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1529841903</pqid></control><display><type>article</type><title>Epitope distribution in ordered and disordered protein regions. Part B — Ordered regions and disordered binding sites are targets of T- and B-cell immunity</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Pavlovic, Mirjana D ; Jandrlic, Davorka R ; Mitic, Nenad S</creator><creatorcontrib>Pavlovic, Mirjana D ; Jandrlic, Davorka R ; Mitic, Nenad S</creatorcontrib><description>Intrinsically disordered proteins exist in highly flexible conformational states linked to different protein functions. In this work, we have presented evidence that HLA class-I- and class-II-binding T-cell epitopes, experimentally verified in several tumor-associated antigens and nuclear systemic autoantigens, are predominantly located in ordered protein regions or at disorder/order borderlines, defined by the majority of analyzed publicly available disorder predictors. We have also observed the overlapping of secondary structural elements and prevalently hydrophobic regions with T-cell epitopes in Epstein Barr Virus (EBV) nuclear antigen 1 (EBNA-1), cancer/testis antigen MAGE-A4, and Sm-B/B′, U1 snRNPA (U1A) and U1-70kDa autoantigens. The results are in accordance with the clustering of the predicted HLA class-I and class-II epitopes in protein parts which encompass the consensus of ordered regions, determined by individual disorder predictors. Some HLA class-II epitopes and linear B-cell epitopes were located near the segments predicted to have elevated crystallographic B factor in EBNA-1, Sm-B/B′ and U1 snRNP A proteins, suggesting that protein flexibility could influence the structural availability of epitopes. Naturally processed T-cell epitopes and linear B-cell epitopes could also be found within putative disordered binding sites, determined by “dips” in the prevalently disordered parts of prediction profiles of the majority of disorder predictors, and peaks in ANCHOR-prediction profile. Two minor antigenic regions within EBNA-1, mapped to the residues 58–85 and 398–458, encompassing putative disordered binding sites, contain epitopes connected with anti-Ro 60kDa and anti-Sm B/B′ autoimmunity in systemic lupus erythematosus. One of these regions overlaps residues 395–450, identified as the binding site of USP7 (HAUSP), which regulates the EBNA-1 replication function. In Sm-B/B′, one of the putative disordered binding sites (residues 114–165) encompasses the T-cell epitope 136–153, while another, residues 200–216, flanks two proline-rich B-cell epitopes (residues 190–198 and 216–222), overlapping the preferred CD2BP2–GYF-binding motif (R/K/G)XXPPGX(R/K), characteristic of splicosomal proteins. We have noticed that the same motif (residues 397–403) is mimicked in EBNA-1 and overlaps epitope 398–404, involved in anti-Sm B/B′ autoimmunity. The majority of recognized T- and B-cell epitopes in analyzed autoantigens or tumor-associated antigens appertain to the ordered or transient protein structures. The congruence between certain B- and T-cell epitopes and predicted disordered binding sites or protein-binding eukaryotic motifs in the antigens participating in molecular complexes might influence the capture of antigens, their processing and subsequent presentation and immunodominance. [Display omitted]</description><identifier>ISSN: 0022-1759</identifier><identifier>EISSN: 1872-7905</identifier><identifier>DOI: 10.1016/j.jim.2014.03.027</identifier><identifier>PMID: 24726865</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Antigens, Neoplasm - chemistry ; Antigens, Neoplasm - metabolism ; Autoimmunity ; B-Lymphocytes - immunology ; Cancer ; Disorder prediction ; Disordered binding sites ; Epitope Mapping - methods ; Epitope structural availability ; Epitopes, B-Lymphocyte - chemistry ; Epitopes, B-Lymphocyte - metabolism ; Epitopes, T-Lymphocyte - chemistry ; Epitopes, T-Lymphocyte - metabolism ; Epstein-Barr virus ; Epstein-Barr Virus Nuclear Antigens - chemistry ; Epstein-Barr Virus Nuclear Antigens - metabolism ; HLA Antigens - metabolism ; Humans ; Immunity, Cellular ; Lupus Erythematosus, Systemic - immunology ; Male ; Neoplasm Proteins - chemistry ; Neoplasm Proteins - metabolism ; Peptides - chemistry ; Peptides - metabolism ; Phosphoproteins - chemistry ; Phosphoproteins - metabolism ; Protein Binding ; Protein Conformation ; Ribonucleoprotein, U1 Small Nuclear - chemistry ; Ribonucleoprotein, U1 Small Nuclear - metabolism ; Structure-Activity Relationship ; T-cell epitope prediction ; T-Lymphocytes - immunology ; Testicular Neoplasms - immunology ; Trans-Activators - chemistry ; Trans-Activators - metabolism</subject><ispartof>Journal of immunological methods, 2014-05, Vol.407, p.90-107</ispartof><rights>2014 Elsevier B.V.</rights><rights>Copyright © 2014 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c386t-3526b37e1bdeed73b746599c7329bd642dbd17e5fa14a0b262212af757794ee93</citedby><cites>FETCH-LOGICAL-c386t-3526b37e1bdeed73b746599c7329bd642dbd17e5fa14a0b262212af757794ee93</cites><orcidid>0000-0002-1802-5594</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jim.2014.03.027$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24726865$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pavlovic, Mirjana D</creatorcontrib><creatorcontrib>Jandrlic, Davorka R</creatorcontrib><creatorcontrib>Mitic, Nenad S</creatorcontrib><title>Epitope distribution in ordered and disordered protein regions. Part B — Ordered regions and disordered binding sites are targets of T- and B-cell immunity</title><title>Journal of immunological methods</title><addtitle>J Immunol Methods</addtitle><description>Intrinsically disordered proteins exist in highly flexible conformational states linked to different protein functions. In this work, we have presented evidence that HLA class-I- and class-II-binding T-cell epitopes, experimentally verified in several tumor-associated antigens and nuclear systemic autoantigens, are predominantly located in ordered protein regions or at disorder/order borderlines, defined by the majority of analyzed publicly available disorder predictors. We have also observed the overlapping of secondary structural elements and prevalently hydrophobic regions with T-cell epitopes in Epstein Barr Virus (EBV) nuclear antigen 1 (EBNA-1), cancer/testis antigen MAGE-A4, and Sm-B/B′, U1 snRNPA (U1A) and U1-70kDa autoantigens. The results are in accordance with the clustering of the predicted HLA class-I and class-II epitopes in protein parts which encompass the consensus of ordered regions, determined by individual disorder predictors. Some HLA class-II epitopes and linear B-cell epitopes were located near the segments predicted to have elevated crystallographic B factor in EBNA-1, Sm-B/B′ and U1 snRNP A proteins, suggesting that protein flexibility could influence the structural availability of epitopes. Naturally processed T-cell epitopes and linear B-cell epitopes could also be found within putative disordered binding sites, determined by “dips” in the prevalently disordered parts of prediction profiles of the majority of disorder predictors, and peaks in ANCHOR-prediction profile. Two minor antigenic regions within EBNA-1, mapped to the residues 58–85 and 398–458, encompassing putative disordered binding sites, contain epitopes connected with anti-Ro 60kDa and anti-Sm B/B′ autoimmunity in systemic lupus erythematosus. One of these regions overlaps residues 395–450, identified as the binding site of USP7 (HAUSP), which regulates the EBNA-1 replication function. In Sm-B/B′, one of the putative disordered binding sites (residues 114–165) encompasses the T-cell epitope 136–153, while another, residues 200–216, flanks two proline-rich B-cell epitopes (residues 190–198 and 216–222), overlapping the preferred CD2BP2–GYF-binding motif (R/K/G)XXPPGX(R/K), characteristic of splicosomal proteins. We have noticed that the same motif (residues 397–403) is mimicked in EBNA-1 and overlaps epitope 398–404, involved in anti-Sm B/B′ autoimmunity. The majority of recognized T- and B-cell epitopes in analyzed autoantigens or tumor-associated antigens appertain to the ordered or transient protein structures. The congruence between certain B- and T-cell epitopes and predicted disordered binding sites or protein-binding eukaryotic motifs in the antigens participating in molecular complexes might influence the capture of antigens, their processing and subsequent presentation and immunodominance. [Display omitted]</description><subject>Antigens, Neoplasm - chemistry</subject><subject>Antigens, Neoplasm - metabolism</subject><subject>Autoimmunity</subject><subject>B-Lymphocytes - immunology</subject><subject>Cancer</subject><subject>Disorder prediction</subject><subject>Disordered binding sites</subject><subject>Epitope Mapping - methods</subject><subject>Epitope structural availability</subject><subject>Epitopes, B-Lymphocyte - chemistry</subject><subject>Epitopes, B-Lymphocyte - metabolism</subject><subject>Epitopes, T-Lymphocyte - chemistry</subject><subject>Epitopes, T-Lymphocyte - metabolism</subject><subject>Epstein-Barr virus</subject><subject>Epstein-Barr Virus Nuclear Antigens - chemistry</subject><subject>Epstein-Barr Virus Nuclear Antigens - metabolism</subject><subject>HLA Antigens - metabolism</subject><subject>Humans</subject><subject>Immunity, Cellular</subject><subject>Lupus Erythematosus, Systemic - immunology</subject><subject>Male</subject><subject>Neoplasm Proteins - chemistry</subject><subject>Neoplasm Proteins - metabolism</subject><subject>Peptides - chemistry</subject><subject>Peptides - metabolism</subject><subject>Phosphoproteins - chemistry</subject><subject>Phosphoproteins - metabolism</subject><subject>Protein Binding</subject><subject>Protein Conformation</subject><subject>Ribonucleoprotein, U1 Small Nuclear - chemistry</subject><subject>Ribonucleoprotein, U1 Small Nuclear - metabolism</subject><subject>Structure-Activity Relationship</subject><subject>T-cell epitope prediction</subject><subject>T-Lymphocytes - immunology</subject><subject>Testicular Neoplasms - immunology</subject><subject>Trans-Activators - chemistry</subject><subject>Trans-Activators - metabolism</subject><issn>0022-1759</issn><issn>1872-7905</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc1u1DAUhS0EokPhAdggL9kkXNuJHYsVrcqPVKldlLVlxzcjjybJYDtI3fUh2PJyPAmezpRFF2V1ZZ3vHN3rQ8hbBjUDJj9s6k0Yaw6sqUHUwNUzsmKd4pXS0D4nKwDOK6ZafUJepbQBAAYSXpIT3iguO9muyO-LXcjzDqkPKcfglhzmiYaJztFjRE_t5Pfaw3MX54xFjrguYKrptY2ZntE_d7_o1ZE5ao-tLkw-TGuaQsYiRqTZxjXmROeB3lT3-FnV43ZLwzguU8i3r8mLwW4TvjnOU_L988XN-dfq8urLt_NPl1UvOpkr0XLphELmPKJXwqlGtlr3SnDtvGy4d54pbAfLGguOS84Zt4NqldINohan5P0ht5z3Y8GUzRjSfhM74bwkw5QSHZdCyv-jLdddwzSIgrID2sc5pYiD2cUw2nhrGJh9gWZjSoFmX6ABYUqBxfPuGL-4Ef0_x0NjBfh4ALD8x8-A0aQ-4NSjDxH7bPwcnoj_C6WOrZ4</recordid><startdate>20140501</startdate><enddate>20140501</enddate><creator>Pavlovic, Mirjana D</creator><creator>Jandrlic, Davorka R</creator><creator>Mitic, Nenad S</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7T5</scope><scope>H94</scope><orcidid>https://orcid.org/0000-0002-1802-5594</orcidid></search><sort><creationdate>20140501</creationdate><title>Epitope distribution in ordered and disordered protein regions. Part B — Ordered regions and disordered binding sites are targets of T- and B-cell immunity</title><author>Pavlovic, Mirjana D ; Jandrlic, Davorka R ; Mitic, Nenad S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c386t-3526b37e1bdeed73b746599c7329bd642dbd17e5fa14a0b262212af757794ee93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Antigens, Neoplasm - chemistry</topic><topic>Antigens, Neoplasm - metabolism</topic><topic>Autoimmunity</topic><topic>B-Lymphocytes - immunology</topic><topic>Cancer</topic><topic>Disorder prediction</topic><topic>Disordered binding sites</topic><topic>Epitope Mapping - methods</topic><topic>Epitope structural availability</topic><topic>Epitopes, B-Lymphocyte - chemistry</topic><topic>Epitopes, B-Lymphocyte - metabolism</topic><topic>Epitopes, T-Lymphocyte - chemistry</topic><topic>Epitopes, T-Lymphocyte - metabolism</topic><topic>Epstein-Barr virus</topic><topic>Epstein-Barr Virus Nuclear Antigens - chemistry</topic><topic>Epstein-Barr Virus Nuclear Antigens - metabolism</topic><topic>HLA Antigens - metabolism</topic><topic>Humans</topic><topic>Immunity, Cellular</topic><topic>Lupus Erythematosus, Systemic - immunology</topic><topic>Male</topic><topic>Neoplasm Proteins - chemistry</topic><topic>Neoplasm Proteins - metabolism</topic><topic>Peptides - chemistry</topic><topic>Peptides - metabolism</topic><topic>Phosphoproteins - chemistry</topic><topic>Phosphoproteins - metabolism</topic><topic>Protein Binding</topic><topic>Protein Conformation</topic><topic>Ribonucleoprotein, U1 Small Nuclear - chemistry</topic><topic>Ribonucleoprotein, U1 Small Nuclear - metabolism</topic><topic>Structure-Activity Relationship</topic><topic>T-cell epitope prediction</topic><topic>T-Lymphocytes - immunology</topic><topic>Testicular Neoplasms - immunology</topic><topic>Trans-Activators - chemistry</topic><topic>Trans-Activators - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pavlovic, Mirjana D</creatorcontrib><creatorcontrib>Jandrlic, Davorka R</creatorcontrib><creatorcontrib>Mitic, Nenad S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Journal of immunological methods</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pavlovic, Mirjana D</au><au>Jandrlic, Davorka R</au><au>Mitic, Nenad S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Epitope distribution in ordered and disordered protein regions. Part B — Ordered regions and disordered binding sites are targets of T- and B-cell immunity</atitle><jtitle>Journal of immunological methods</jtitle><addtitle>J Immunol Methods</addtitle><date>2014-05-01</date><risdate>2014</risdate><volume>407</volume><spage>90</spage><epage>107</epage><pages>90-107</pages><issn>0022-1759</issn><eissn>1872-7905</eissn><abstract>Intrinsically disordered proteins exist in highly flexible conformational states linked to different protein functions. In this work, we have presented evidence that HLA class-I- and class-II-binding T-cell epitopes, experimentally verified in several tumor-associated antigens and nuclear systemic autoantigens, are predominantly located in ordered protein regions or at disorder/order borderlines, defined by the majority of analyzed publicly available disorder predictors. We have also observed the overlapping of secondary structural elements and prevalently hydrophobic regions with T-cell epitopes in Epstein Barr Virus (EBV) nuclear antigen 1 (EBNA-1), cancer/testis antigen MAGE-A4, and Sm-B/B′, U1 snRNPA (U1A) and U1-70kDa autoantigens. The results are in accordance with the clustering of the predicted HLA class-I and class-II epitopes in protein parts which encompass the consensus of ordered regions, determined by individual disorder predictors. Some HLA class-II epitopes and linear B-cell epitopes were located near the segments predicted to have elevated crystallographic B factor in EBNA-1, Sm-B/B′ and U1 snRNP A proteins, suggesting that protein flexibility could influence the structural availability of epitopes. Naturally processed T-cell epitopes and linear B-cell epitopes could also be found within putative disordered binding sites, determined by “dips” in the prevalently disordered parts of prediction profiles of the majority of disorder predictors, and peaks in ANCHOR-prediction profile. Two minor antigenic regions within EBNA-1, mapped to the residues 58–85 and 398–458, encompassing putative disordered binding sites, contain epitopes connected with anti-Ro 60kDa and anti-Sm B/B′ autoimmunity in systemic lupus erythematosus. One of these regions overlaps residues 395–450, identified as the binding site of USP7 (HAUSP), which regulates the EBNA-1 replication function. In Sm-B/B′, one of the putative disordered binding sites (residues 114–165) encompasses the T-cell epitope 136–153, while another, residues 200–216, flanks two proline-rich B-cell epitopes (residues 190–198 and 216–222), overlapping the preferred CD2BP2–GYF-binding motif (R/K/G)XXPPGX(R/K), characteristic of splicosomal proteins. We have noticed that the same motif (residues 397–403) is mimicked in EBNA-1 and overlaps epitope 398–404, involved in anti-Sm B/B′ autoimmunity. The majority of recognized T- and B-cell epitopes in analyzed autoantigens or tumor-associated antigens appertain to the ordered or transient protein structures. The congruence between certain B- and T-cell epitopes and predicted disordered binding sites or protein-binding eukaryotic motifs in the antigens participating in molecular complexes might influence the capture of antigens, their processing and subsequent presentation and immunodominance. [Display omitted]</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>24726865</pmid><doi>10.1016/j.jim.2014.03.027</doi><tpages>18</tpages><orcidid>https://orcid.org/0000-0002-1802-5594</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0022-1759
ispartof Journal of immunological methods, 2014-05, Vol.407, p.90-107
issn 0022-1759
1872-7905
language eng
recordid cdi_proquest_miscellaneous_1773826366
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Antigens, Neoplasm - chemistry
Antigens, Neoplasm - metabolism
Autoimmunity
B-Lymphocytes - immunology
Cancer
Disorder prediction
Disordered binding sites
Epitope Mapping - methods
Epitope structural availability
Epitopes, B-Lymphocyte - chemistry
Epitopes, B-Lymphocyte - metabolism
Epitopes, T-Lymphocyte - chemistry
Epitopes, T-Lymphocyte - metabolism
Epstein-Barr virus
Epstein-Barr Virus Nuclear Antigens - chemistry
Epstein-Barr Virus Nuclear Antigens - metabolism
HLA Antigens - metabolism
Humans
Immunity, Cellular
Lupus Erythematosus, Systemic - immunology
Male
Neoplasm Proteins - chemistry
Neoplasm Proteins - metabolism
Peptides - chemistry
Peptides - metabolism
Phosphoproteins - chemistry
Phosphoproteins - metabolism
Protein Binding
Protein Conformation
Ribonucleoprotein, U1 Small Nuclear - chemistry
Ribonucleoprotein, U1 Small Nuclear - metabolism
Structure-Activity Relationship
T-cell epitope prediction
T-Lymphocytes - immunology
Testicular Neoplasms - immunology
Trans-Activators - chemistry
Trans-Activators - metabolism
title Epitope distribution in ordered and disordered protein regions. Part B — Ordered regions and disordered binding sites are targets of T- and B-cell immunity
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T04%3A57%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Epitope%20distribution%20in%20ordered%20and%20disordered%20protein%20regions.%20Part%20B%20%E2%80%94%20Ordered%20regions%20and%20disordered%20binding%20sites%20are%20targets%20of%20T-%20and%20B-cell%20immunity&rft.jtitle=Journal%20of%20immunological%20methods&rft.au=Pavlovic,%20Mirjana%20D&rft.date=2014-05-01&rft.volume=407&rft.spage=90&rft.epage=107&rft.pages=90-107&rft.issn=0022-1759&rft.eissn=1872-7905&rft_id=info:doi/10.1016/j.jim.2014.03.027&rft_dat=%3Cproquest_cross%3E1529841903%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1529841903&rft_id=info:pmid/24726865&rft_els_id=S0022175914001161&rfr_iscdi=true